|
|
|
Year :2022
|
Month :
April
|
Volume :
10
|
Issue :
2
|
Page :
PO33 - PO36
|
Cutaneous Manifestations Among Hospitalised COVID-19 Infected Children from Northern India: A Cross-sectional Study
|
|
|
Correspondence Address :
Ashish Dalal, Arti Dhingra, Deepak Jakhar, Janshruti, Vaibhav, Ritambhara Lohan, Jyoti Sangwan,
Dr. Ashish Dalal,
Room No 4, SHKM, Hospital, Nalhar, NUH, Haryana, India.
E-mail: ashishdalal6008@gmail.com
|
|
Introduction: Novel Coronavirus Disease-2019 (COVID-19) is caused by Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2). Besides the systemic manifestations, mucocutaneous involvement has also been reported with COVID-19. Reports suggest that the mucocutaneous manifestations may differ in children and adult patients.
Aim: To describe the prevalence and characteristics of cutaneous manifestations among COVID-19 infected children.
Materials and Methods: This descriptive cross-sectional study was undertaken in Shaheed Hasan Khan Mewati, Government Medical College and Hospital, Nuh, Haryana, India. Total 50 SARS-CoV-2 positive children, admitted during the study period (between July to December, 2020) and fulfilling inclusion criteria were screened for mucocutaneous manifestations. Findings were recorded on a predesigned proforma. The data was statistically analysed and significant association between findings was recorded.
Results: Total 50 (4.56%) children out of 1095 were positive for SARS-CoV-2 by Reverse Transcription Polymerase Chain Reaction (RT-PCR) test and were admitted in Isolation Ward. Male to female ratio was 3:2 in present study. Four children had cutaneous manifestation: maculopapular rash (3/50) and urticarial lesions (1/50). All four patients had mild to moderate severity of disease. None of the patient had mucosal involvement.
Conclusion: Appearance of dermatological findings among 8% of COVID-19 positive children warrants that all COVID-19 positive children should be screened for cutaneous findings.
|
|
|
[
FULL TEXT ] | [
 ]
|
|
|
|
|